Biogen Inc. (BIIB)

NASDAQ: BIIB · Real-Time Price · USD

254.81

+6.46 (2.60%)

At close: Nov 9, 2026, 4:00 PM EST

254.88

+0.07 (0.03%)

After-hours: Nov 9, 2026, 6:15 PM EST

Biogen Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	37,666	25,818	22,283	37,495	39,877	35,242
Market Cap Growth	67.34%	15.86%	-40.57%	-5.97%	13.15%	-6.47%
Enterprise Value	44,163	28,448	27,235	42,918	40,731	39,390
Last Close Price	254.87	175.99	152.92	258.77	276.92	239.92

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	109.07	19.97	13.65	32.29	13.09	22.65
Forward PE	17.27	13.66	9.71	17.54	17.70	13.94
PS Ratio	3.66	2.61	2.30	3.81	3.92	3.21
PB Ratio	1.99	1.41	1.33	2.53	2.98	3.22
P/TBV Ratio	-	9.98	40.82	172.63	6.88	12.10
P/FCF Ratio	18.19	12.59	8.19	29.52	34.86	10.42
P/OCF Ratio	16.77	11.71	7.75	24.23	28.81	9.68
PEG Ratio	1.84	4.75	1.90	4.38	17.68	39.30

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.29	2.88	2.82	4.36	4.00	3.59
EV/EBITDA Ratio	13.38	7.84	8.29	17.93	11.52	10.04
EV/EBIT Ratio	18.25	9.99	10.42	22.60	13.49	11.47
EV/FCF Ratio	21.33	13.87	10.01	33.79	35.60	11.65

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.41	0.37	0.40	0.50	0.50	0.70
Debt / EBITDA Ratio	2.28	1.78	1.97	2.93	1.85	1.91
Debt / FCF Ratio	3.77	3.25	2.47	5.85	5.87	2.28
Net Debt / Equity Ratio	0.34	0.13	0.26	0.43	0.08	0.27
Net Debt / EBITDA Ratio	1.97	0.66	1.32	2.67	0.32	0.76
Net Debt / FCF Ratio	3.14	1.18	1.60	5.02	0.97	0.89
Asset Turnover	0.34	0.34	0.35	0.38	0.42	0.45
Inventory Turnover	1.13	0.90	0.85	1.31	1.69	1.74
Quick Ratio	0.95	1.70	0.77	1.04	2.39	1.34
Current Ratio	1.95	2.68	1.35	2.00	2.99	1.83
Return on Equity (ROE)	1.87%	7.39%	10.36%	8.24%	24.33%	15.96%
Return on Assets (ROA)	4.94%	6.19%	5.95%	4.62%	7.79%	8.86%
Return on Invested Capital (ROIC)	7.36%	11.22%	10.60%	9.35%	16.55%	21.63%
Return on Capital Employed (ROCE)	8.60%	10.90%	11.60%	8.10%	14.20%	17.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.92%	5.01%	7.32%	3.10%	7.64%	4.42%
FCF Yield	5.50%	7.94%	12.21%	3.39%	2.87%	9.60%
Buyback Yield / Dilution	-1.49%	-0.82%	-0.21%	0.27%	2.41%	7.25%

SEC Filings: 10-K · 10-Q